Characterization of a novel, high-affinity and selective fluorescent antagonist for the 5HT1A receptor

被引：0
|
作者：
Fatokun, Amos Akintayo [1 ]
Middleton, Richard J. [2 ]
Thompson, Kevin S. J. [2 ]
Briddon, Stephen J. [1 ]
Hill, Stephen J. [1 ]
机构：
[1] Univ Nottingham, Inst Cell Signalling, Sch Biomed Sci, Nottingham NG7 2UH, England
[2] CellAura Technol Ltd, BioCity, Nottingham NG1 1GF, England
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
655.4
引用
收藏
页数：1
相关论文
共 50 条
  • [1] GR113808 - A NOVEL, SELECTIVE ANTAGONIST WITH HIGH-AFFINITY AT THE 5-HT4 RECEPTOR
    GALE, JD
    GROSSMAN, CJ
    WHITEHEAD, JWF
    OXFORD, AW
    BUNCE, KT
    HUMPHREY, PPA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (01) : 332 - 338
  • [2] High-affinity fluorescent ligands for the 5-HT3 receptor
    Simonin, Jonathan
    Vernekar, Sanjeev Kumar V.
    Thompson, Andrew J.
    Hothersall, J. Daniel
    Connolly, Christopher N.
    Lummis, Sarah C. R.
    Lochner, Martin
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1151 - 1155
  • [3] RS-100235 - A HIGH-AFFINITY 5-HT4 RECEPTOR ANTAGONIST
    CLARK, RD
    JAHANGIR, A
    FLIPPIN, LA
    LANGSTON, JA
    LEUNG, E
    BONHAUS, DW
    WONG, EHF
    JOHNSON, LG
    EGLEN, RM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (18) : 2119 - 2122
  • [4] Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX2 receptor
    Malherbe, P.
    Borroni, E.
    Gobbi, L.
    Knust, H.
    Nettekoven, M.
    Pinard, E.
    Roche, O.
    Rogers-Evans, M.
    Wettstein, J. G.
    Moreau, J-L
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (08) : 1326 - 1341
  • [5] A novel, high-affinity, fluorescent progesterone receptor antagonist. synthesis and in vitro studies
    Hödl, C
    Strauss, WSL
    Sailer, R
    Seger, C
    Steiner, R
    Haslinger, E
    Schramm, HW
    [J]. BIOCONJUGATE CHEMISTRY, 2004, 15 (02) : 359 - 365
  • [6] A novel high-affinity peptide antagonist to the insulin receptor
    Schaffer, Lauge
    Brand, Christian L.
    Hansen, Bo F.
    Ribel, Ulla
    Shaw, Allan C.
    Slaaby, Rita
    Sturis, Jeppe
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 376 (02) : 380 - 383
  • [7] RS-102221: A novel high affinity and selective, 5-HT2C receptor antagonist
    Bonhaus, DW
    Weinhardt, KK
    Taylor, M
    Desouza, A
    Mcneeley, PM
    Szczepanski, K
    Fontana, DJ
    Trinh, J
    Rocha, CL
    Dawson, MW
    Flippin, LA
    Eglen, RM
    [J]. NEUROPHARMACOLOGY, 1997, 36 (4-5) : 621 - 629
  • [8] RS-127445: A selective, high-affinity, orally bioavailable 5-HT2B receptor antagonist.
    Flippin, LA
    Bonhaus, DW
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U971 - U971
  • [9] BLOCKADE OF HUMAN ATRIAL 5-HT4 RECEPTORS BY SB-207710, A SELECTIVE AND HIGH-AFFINITY 5-HT4 RECEPTOR ANTAGONIST
    KAUMANN, AJ
    GASTER, LM
    KING, FD
    BROWN, AM
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1994, 349 (05) : 546 - 548
  • [10] A NOVEL SITE OF ACTION OF A HIGH-AFFINITY A1 ADENOSINE RECEPTOR ANTAGONIST
    RAMKUMAR, V
    STILES, GL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 153 (03) : 939 - 944
12345